Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the CAGR of the Erythropoietin (EPO) Market Influence Its Overall Growth by 2034?

In the past few years, the erythropoietin (EPO) market has seen fast-paced growth. The market size is expected to surge from $17.29 billion in 2024 to $19.25 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. This rampant growth during the historic period can be traced back to factors such as enhanced patient education and awareness, mergers in the pharmaceutical industry, health insurance reimbursement policies, market proliferation and rising demand, the expiration of patents and the introduction of biosimilars.

In the coming years, a swift expansion is anticipated in the erythropoietin (EPO) market. This will rocket it to an estimated worth of $30.92 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 12.6%. The growth during this forecasted period can be credited to factors such as market rivalry and the effect of biosimilar, projected disease prevalence rates, changes in healthcare policy and reimbursement, the expansion of emerging markets, and the concentration on clinical trials and research. Significant trends within this period are expected to encompass supply chain management, global enlargement and emerging markets, patient enlightenment and awareness, reimbursement strategies, as well as market consolidation and mergers.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Erythropoietin (EPO) Market?

The escalating number of chronic kidney disease cases is expected to fuel the need for the erythropoietin market in the forthcoming years. The surge in chronic kidney disease cases necessitates the use of erythropoietin, essential in the production of red blood cells which boost immunity. For instance, per data from the Centers for Disease Control, a US federal agency, in 2023, around 14% of U.S. adults, representing roughly 35.5 million people, are projected to suffer from chronic kidney disease (CKD). Therefore, the increase in chronic kidney disease frequency heightens the need for erythropoietin, consequently propelling market revenues.

Request Your Free Erythropoietin (EPO) Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

Who Are the Leading Companies Pioneering Change in the Erythropoietin (EPO) Market?

Major companies operating in the erythropoietin (EPO) market include Amgen Inc., Roche Holding AG, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Ltd., 3SBio Inc., Celltrion Inc., Intas Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Reliance Life Sciences Pvt. Ltd., Biocon Limited, Chugai Pharmaceutical Co., Kyowa Kirin Co. Ltd., Apotex Inc., CJ Healthcare Corp., STADA Arzneimittel AG, Hospira Inc., Sandoz International GmbH, Torrent Pharmaceuticals Ltd., LG Life Sciences Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals.

How Are Consumer Trends Shaping the Current and Future Landscape of the Erythropoietin (EPO) Market?

Prominent corporations in the erythropoietin market are emphasizing the development and launch of oral drugs as more user-friendly options compared to traditional injection-based treatments. The objective is to enhance patient convenience, adherence to medication and offer flexible treatment options, especially for those dealing with chronic illnesses such as anemia associated with chronic kidney disease (CKD). In February 2023, for example, the renowned UK-based pharmaceutical and biotechnology firm, GlaxoSmithKline (GSK), introduced Jesduvroq (daprodustat) tablets to the market. These tablets serve to raise erythropoietin levels, enabling the effective management of anemia in CKD patients by maintaining hemoglobin levels in a target range. Jesduvroq is designed to present a more suitable option for patients than injectable therapies, intending to enhance comfort, medication adherence, and flexible treatment for those undergoing dialysis.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

What Are the Core Categories and Segments in the Erythropoietin (EPO) Market Driving Demand and Growth?

The erythropoietin (EPO) market covered in this report is segmented –

1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products

2) By Drug Class: Biologist, Biosimilar

3) By Application: Cancer, Hematology, Renal Diseases, Neurology, Other Applications

Subsegments:

1) By Epoetin-Alfa: Epoetin-Alfa, Epoetin-Alfa Biosimilars

2) By Epoetin-Beta: Epoetin-Beta, Epoetin-Beta Biosimilars

3) By Darbepoetin-Alfa: Darbepoetin-Alfa, Darbepoetin-Alfa Biosimilars

4) By Other Products: Peginesatide, Other Novel EPO Products

Which Regions Are Leading the Charge in Erythropoietin (EPO) Market Development?

The countries covered in the erythropoietin (epo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

How Is the Scope and Reach of the Erythropoietin (EPO) Market Defined?

Erythropoietin (EPO) refers to a glycoprotein hormone that naturally induces the generation of red blood cells and is produced by the kidney’s peritubular cells. Red blood cell scarcity, or anemia, is treated with it. Weakness, weariness, and shortness of breath are signs of anemia because red blood cells deliver oxygen to the tissues and organs.

Browse Through More Similar Reports By The Business Research Company:

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Proteomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Protein Inhibitors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: